Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal

Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163937936.html">Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal</a></p> <p>Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study.</p>